SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Agilis NxT

STEERABLE INTRODUCER

Agilis NxT
About

13 Fr: The Newest Addition to Our Agilis™ NxT Steerable Introducer Family

The market-leading Agilis NxT Steerable Introducer is now compatible with larger catheters to support all therapy deliveries from PFA to RF to CRYO - for an optimal workflow with our One System Solution. Introducing the Agilis NxT Steerable Introducer, Dual‑Reach™ (13 Fr).

Agelis NxT

Market-leading Agilis NxT Steerable Introducer now compatible with larger catheters with the introduction of Agilis NxT Steerable Introducer, Dual-Reach (13 Fr).

ATRAUMATIC TIP
New low-profile design and atraumatic tip

 

SIX OFF SET VENTING HOLES
Smaller diameter (.030”) and 90º offset reduces the likelihood of guidewire exiting through side holes

 

RADIO-OPAQUE TIP MARKER
Ring of platinum iridium enables visualization under fluoro; 4 mm from tip

 

SHEATH TO DILATOR FIT
Low-profile design with lower transeptal crossing force

 

BRAIDED SHAFT
Provides exceptional torquability, pushability and kink resistance with Dual-Reach™ bidirectional 180˚/90˚ deflection to allow asymmetric deflection for more mobility

 

BI-DIRECTIONAL; ROTATING COLLAR
To deflect the tip clockwise ≥180° and counterclockwise ≥90° auto locking

 

HEMOSTASIS VALVE
3-way stopcock for air or blood aspiration, fluid infusion, blood sampling

8.5 Fr: Choose the Gold Standard

As evidenced in more than one million procedures*, for a growing number of physicians, Agilis NxT Steerable Introducer (8.5 Fr) is the introducer of choice when guiding ablation catheters to treat arrhythmias. Tailor to your patient’s anatomy with a large variety of sizes and curves that maintain their shape

Agelis NxT curve options

Curves shown is for 8.5 Fr Agilis NxT Steerable Introducer

Confident steering and stable positioning with exceptional maneuverability

Enhanced catheter stability enables control of tip movements within millimeters along the intended ablation line1

Access hard-to-reach areas with precise maneuverability and auto-lock steering, such as the right inferior and left anterior pulmonary veins1

Enhanced procedural efficiency with exceptional contact force.

60%

Greater catheter-tissue contact force, which may support more durable lesion formation2

 

Reliable, Complete Lesion Creation Through Outstanding Agility and Stability

 

Greater freedom from arrhythmia at 6 months (76.0% vs 53.0%)3 and 18% greater at 12 months (74.0% vs 62.7%)4

 

Complete PVI isolation (left- and right-sided veins) (43 pts vs 8 pts)1

 

Fewer re-do ablations (6 pts vs 23 pts)1 and 17% fewer acute PV reconnections (50% vs 60%)5

This device is commercially available for use in select international markets.

BOLD SOLUTIONS
TO CHALLENGE AFIB

Learn More
Bold Solutions to challenge AFIB
Manuals & Resources

Manuals & Resources

Cardiovascular Products

Cardiovascular Products

Customer Service

Customer Service

*Based on sales through Dec 31, 2020

Information herein intended for distribution outside the U.S. only, excluding Finland.

References

  1. Piorkowski C, et al. (2008). Steerable sheath catheter navigation for ablation of atrial fibrillation: A case-control study. Pacing and Clinical Electrophysiology, 31(7), 863–873.
  2. Cuoco F, et al. (2014). Steerable sheath promotes improved contact force parameters during pulmonary vein isolation. Heart Rhythm, Vol. 11, No. 5, May Supplement.
  3. Piorkowski C, et al. (2011). Steerable versus non-steerable sheath technology in AF ablation: A prospective, randomized study. Circulation, 4(2), 157–165.
  4. Mansour M. (2014). TOCCASTAR: Preliminary Results of the First Prospective Randomized Study of a Contact Force Sensing Ablation Catheter for the Treatment of Paroxysmal AF. Presented at HRS AF Summit 2014. San Francisco, California.
  5. Hutchinson M, et al. (2013). Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm, 10(3), 347–353.

MAT-2414395 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-2001111 v8.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0